Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,382,550
  • Shares Outstanding, K 30,160
  • Annual Sales, $ 10,440 K
  • Annual Income, $ -166,900 K
  • 36-Month Beta 2.61
  • Price/Sales 249.02
  • Price/Cash Flow N/A
  • Price/Book 8.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -2.39
  • Number of Estimates 2
  • High Estimate -2.13
  • Low Estimate -2.64
  • Prior Year -2.18
  • Growth Rate Est. (year over year) -9.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
137.27 +3.88%
on 10/11/18
179.65 -20.63%
on 09/27/18
-11.05 (-7.19%)
since 09/19/18
3-Month
125.50 +13.62%
on 08/07/18
179.65 -20.63%
on 09/27/18
-6.02 (-4.05%)
since 07/19/18
52-Week
101.07 +41.08%
on 10/25/17
179.65 -20.63%
on 09/27/18
+33.19 (+30.34%)
since 10/19/17

Most Recent Stories

More News
Hemp and CBD set to Eclipse the THC Marijuana Market

CannabisNewsWire Editorial Coverage

ACB.TO : 13.01 (-5.45%)
ACBFF : 9.9658 (-5.27%)
TLRY : 145.30 (-4.74%)
GWPH : 142.59 (-1.87%)
SGMD : 0.1275 (-3.99%)
CGC : 46.85 (-4.21%)
Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Aerie Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / October 15, 2018 / U.S. markets bounced on Friday, erasing some of the losses for the week, as the third quarter earnings season kicked off. The Dow Jones Industrial Average...

AERI : 58.38 (+0.22%)
GWPH : 142.59 (-1.87%)
Fresh Acquisitions Help Companies Profit from Growth in the Cannabis Sector

CannabisNewsWire Editorial Coverage

ACBFF : 9.9658 (-5.27%)
TLRY : 145.30 (-4.74%)
GWPH : 142.59 (-1.87%)
SGMD : 0.1275 (-3.99%)
CGC : 46.85 (-4.21%)
Cannabidiol (CBD) Medicinal Products Reaching New Level of Acceptance in the Healthcare Industry

Financialnewsmedia.com News Commentary

EPW.CN : 0.280 (+7.69%)
APH.TO : 18.30 (-5.91%)
WEED.TO : 61.30 (-4.13%)
MMEN.CN : 8.500 (-5.76%)
APHQF : 13.9390 (-6.38%)
GWPH : 142.59 (-1.87%)
EPWCF : 0.2200 (+9.02%)
CGC : 46.85 (-4.21%)
MMNFF : 6.4934 (-5.87%)
Cannabis Industry Service Provider Solving Major Challenges

HENDERSON, NV / ACCESSWIRE / October 5, 2018 / One of the major reasons cannabis stocks are doing so well is because they are potential solutions to long standing challenges, such as the opioid epidemic....

APHQF : 13.9390 (-6.38%)
GWPH : 142.59 (-1.87%)
CGC : 46.85 (-4.21%)
Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector

NEW YORK, October 4, 2018 /PRNewswire/ --

ACBFF : 9.9658 (-5.27%)
GWPH : 142.59 (-1.87%)
LXRP : 1.7500 (-2.78%)
LXX.CN : 2.270 (-0.44%)
CGC : 46.85 (-4.21%)
GW Pharmaceuticals Announces Proposed Public Offering of ADSs

GW Pharmaceuticals plc (Nasdaq: GWPH, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid...

JPM : 107.91 (-0.17%)
MS : 46.42 (+0.85%)
GWPH : 142.59 (-1.87%)
The Hottest CBD Stocks

HENDERSON, NV / ACCESSWIRE / October 1, 2018 / With the DEA rescheduling CBD the top is off, and the time is now to find CBD companies before missing the boat.CBD is a very lucrative business, because...

CARA : 19.67 (-1.45%)
ACBFF : 9.9658 (-5.27%)
GWPH : 142.59 (-1.87%)
CIIX : 0.8051 (-9.54%)
ZYNE : 6.79 (-6.86%)
The Most Exciting Story In The $140 Billion Cannabis Boom

Mark this date down: October 17th. That's the day that Canada fully legalizes recreational cannabis. And that's also the date that the best kept story in the cannabis sector could be revealed. Mentioned...

SCYB.VN : 3.490 (-5.93%)
ITHUF : 5.7100 (-8.70%)
XON : 13.95 (-3.59%)
VLLFF : 2.4000 (unch)
GWPH : 142.59 (-1.87%)
IAN.CN : 7.490 (-8.55%)
TWMJF : 30.2137 (-1.94%)
VFFIF : 5.2060 (-6.20%)
Pot Stocks & ETF: Risks and Rewards

Here is what investors need to know about risks and rewards of investing in the emerging marijuana industry.

CRON : 9.71 (-9.42%)
ACBFF : 9.9658 (-5.27%)
KO : 46.33 (+1.58%)
STZ : 222.93 (-0.96%)
TLRY : 145.30 (-4.74%)
GWPH : 142.59 (-1.87%)
MJ : 37.50 (-4.82%)
CGC : 46.85 (-4.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade GWPH with:

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 150.90
1st Resistance Point 146.75
Last Price 142.59
1st Support Level 140.07
2nd Support Level 137.54

See More

52-Week High 179.65
Fibonacci 61.8% 149.63
Last Price 142.59
Fibonacci 50% 140.36
Fibonacci 38.2% 131.09
52-Week Low 101.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar